Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Post author:Ronald Zahoruk
Post published:January 15, 2020
Post category:Uncategorized

Vasomune Therapeutics is currently attending the 38TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune Therapeutics Announces Clinical and Scientific Advisory Board

Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment

Learn More About Vasomune’s Partnership with University of Iowa Pharmaceuticals’ COVID-19 Drug Manufacturing

About

Vasomune Therapeutics 2020 © All Rights Reserved.